[1]
Sy, M.; Kitazawa, M.; Medeiros, R.; Whitman, L.; Cheng, D.; Lane, T.E.; Laferla, F.M. Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am. J. Pathol., 2011, 178(6), 2811-2822.
[2]
Camoutsis, C.; Geronikaki, A.; Ciric, A.; Soković, M.; Zoumpoulakis, P.; Zervou, M. Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: Synthesis, biological evaluation, lipophilicity, and conformational studies. Chem. Pharm. Bull. (Tokyo), 2010, 58(2), 160-167.
[3]
Jain, A.K.; Sharma, S.; Vaidya, A.; Ravichandran, V.; Agrawal, R.K. 1,3,4-Thiadiazole and its derivatives: A review on recent progress in biological activities. Chem. Biol. Drug Des., 2013, 81(5), 557-576.
[4]
Talapatra, S.K.; Tham, C.L.; Guglielmi, P.; Cirilli, R.; Chandrasekaran, B.; Karpoormath, R.; Carradori, S.; Kozielski, F. Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors. Eur. J. Med. Chem., 2018, 156, 641-651.
[5]
Bachwani, M.; Kumar, R. Molecular docking: A review. Int. J. Res. Ayurveda Pharm., 2011, 2(6), 1746-1751.
[6]
Katsila, T.; Spyroulias, G.A.; Patrinos, G.P.; Matsoukas, M.T. Computational approaches in target identification and drug discovery. Comput. Struct. Biotechnol. J., 2016, 14, 177-184.
[7]
Kushwaha, N.; Kushwaha, S.K.S.; Rai, A.K. Biological activities of thiadiazole derivatives: A review. Int. J. Chemtech Res., 2012, 4(6), 517-531.
[8]
Kavitha, C.V.; Basappa, S.; Swamy, S.N.; Mantelingu, K.; Doreswamy, S.; Sridhar, M.A.; Shashidhara Prasad, J.; Rangappa, K.S. Synthesis of new bioactive venlafaxine analogs: Novel thiazolidin-4-ones as antimicrobials. Bioorg. Med. Chem., 2006, 14(7), 2290-2299.
[9]
Husain, K.; Abid, M.; Azam, A. Synthesis, characterization and antiamoebic activity of new indole-3-carboxaldehyde thiosemicarbazones and their Pd(II) complexes. Eur. J. Med. Chem., 2007, 42(10), 1300-1308.
[10]
Suma, B.V.; Vijayalakshmi, S.; Madhavan, V.; Murali, A. Synthesis and anticonvulsant activities of some novel 1,3,4-thiadiazole derivatives. Med. Chem. Dr. Disc., 2013, 4(2), 100-107.
[11]
Sharshira, E.M.; Hamada, N.M.M. Synthesis, characterization and antimicrobial activities of some thiazole derivatives. Amer. J. Org. Chem., 2012, 2(3), 69-73.
[12]
Beena, K.P. Akelesh. Design, synthesis, characterization and evaluation of some 1,3-oxazine derivatives as potent antimicrobial agents. Der Pharmacia Letter., 2013, 5(4), 257-260.
[13]
Issaca, Y.A.; Mohamed, S.K.; Eissaa, A.E.M.M.F.; Tantawya, A.H.; El-Sawya, A.A. Synthesis of pentadecanyl-amino thiadiazole pharmacophores and their antimicrobial assessments. J. Chem. Pharm. Res., 2012, 4(5), 2744-2750.
[14]
Patneedi, C.B.; Prasadu, K.D.; Sharma, R.S.K. Synthesis of heterocyclic chalconoid derivatives. Pharma. Chem., 2015, 7(8), 10-16.
[15]
Ghareb, N.; Elshihawy, H.A.; Abdel-Daim, M.M.; Helal, M.A. Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2 inhibitors; Ultrasound-assisted synthesis, biological evaluation, and DFT calculations. Bioorg. Med. Chem. Lett., 2017, 27(11), 2377-2383.
[16]
Thanh, N.D.; Giang, N.T.K.; Quyen, T.H.; Huong, D.T.; Toan, V.N. Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones. Eur. J. Med. Chem., 2016, 123, 532-543.
[17]
Balouiri, M.; Sadiki, M.; Ibnsouda, S.K. Methods for in vitro evaluating antimicrobial activity: A review. J. Pharm. Anal., 2016, 6(2), 71-79.
[18]
Hałasa, R.; Turecka, K.; Orlewska, C.; Werel, W. Comparison of fluorescence optical respirometry and microbroth dilution methods for testing antimicrobial compounds. J. Microbiol. Methods, 2014, 107, 98-105.
[19]
Cruickshank, R.; Duguid, J.P.; Marmion, B.P.; Swain, R.H.A. The enterobacteriaceae. Salmonella. Med. Microbiol., 1975, 11, 403-419.
[20]
Cristina, A.; Leonte, D.; Vlase, L.; Bencze, C.L.; Imre, S.; Marc, G.; Apan, B.; Mogoșan, C.; Zaharia, V. Heterocycles 48. Synthesis, characterization and biological evaluation of imidazo[2,1-b][1,3,4]thiadiazole derivatives as anti-inflammatory agents. Molecules, 2018, 23(10), 2425.
[21]
Winter, C.A.; Risley, E.A.; Nuss, G.W. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc. Soc. Exp. Biol. Med., 1962, 111, 544-547.
[22]
Bhati, S.K.; Kumar, A. Synthesis of new substituted azetidinoyl and thiazolidinoyl-1,3,4-thiadiazino (6,5-b) indoles as promising anti-inflammatory agents. Eur. J. Med. Chem., 2008, 43(11), 2323-2330.
[23]
Nadenla, R.R. Molecular Modeling: A Powerful Tool for Drug Designand Molecular Docking. Resonance, 2004, 9(5), 51-60.
[24]
Malleshappa, N.N.; Patel, H.M. A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: A rational approach to anticancer drug design. Saudi J. Chem. Soc., 2013, 17, 361-379.
[25]
Bhuva, H.A.; Kini, S.G. Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitors. J. Mol. Graph. Model., 2010, 29(1), 32-37.
[26]
Onkara; Kumar, A.S.; Kanakaraju, S.; Prasanna, B.; Pydisetty, Y. Molecular docking studies, synthesis and anti-bacterial properties of new mannich bases. Int. J. Pharma Bio Sci., 2013, 4(2), 263-270.
[27]
Rishipathak, D.; Shirodkar, P. Design and molecular docking studies of some 1,3,4-oxadiazole derivatives. Int. J. Pharm. Sci. Rev. Res., 2013, 23(1), 285-289.
[28]
Salman, A.S.; Mahmoud, N.A.; Aziem, A.A.; Mohamed, M.A.; Elsisi, D.M. Synthesis, reactions and antimicrobial activity of some new 3-substituted indole derivatives. Int. J. Org. Chem. (Irvine), 2015, 5, 81-99.
[29]
Buvana, C.; Mahalaksmi, A.; Mathew, B.; Sukumar, M. Synthesis of some thiazolidinone derivatives from indole 2-carboxylic acid and evaluation of its xanthine oxidase inhibitory and antioxidant activity. Int. J. Chemtech Res., 2011, 3, 671-675.
[30]
Farghaly, A.R. Synthesis of some new indole derivatives containing pyrazoles with potential antitumor activity. ARKIVOC, 2010, 6, 177-187.
[31]
Hassan, F.A. Synthesis and biological evaluation of 1,3,4 thiadiazole derivative on some parameters of immunity and liver enzymes. Int. J. Res. Pharm. Chem., 2012, 2(1), 2231-2781.
[32]
Hawaiz, F.E.; Samad, M.K. Synthesis and spectroscopic characterization of some new biological active azo-pyrazoline derivatives. Eur. J. Chem., 2012, 9(3), 1613-1622.
[33]
Pattan, S.R. kekare, P.; Dighe, N.S.; Nirmal, S.A.; Musmade, D.S.; Parjane, S.K.; Daithankar, A.V. Synthesis and biological evaluation of some 1, 3, 4-thiadiazoles. J. Chem., 2009, 1(1), 191-198.
[34]
Ecobichon, D.J. The Basis of Toxicology Testing; CRC Press: New York, 1997, pp. 43-86.
[35]
Upmanyu, N.; Gupta, J.K.; Shah, K.; Mishra, P. Anti-inflammatory and antinociceptive evaluation of newly synthesized 4-(substituted ethanoyl) amino-3-mercapto-5-(4-methoxy) phenyl-1,2,4-triazoles. J. Pharm. Bioallied Sci., 2011, 3(2), 259-265.
69
3
1
1